Market not sure about Rentokil’s $6.7 billion deal merits
After initially receiving garlands from the market with a rising share price, investors quickly became more circumspect on hygiene services and pest control firm Rentokil’s (RTO) $6.7 billion deal for US rival Terminix.
While the strategic logic of the deal is clear, creating a global market leader with a particularly strong footprint in the US and with annual cost synergies of $150 million ...